BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Daunorubicin

A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.

298+ PubMed studies analyzed · 11 RCTs · Evidence Score: 42

Research Domains

Daunorubicin has been studied across 15 research domains including 🔬 Oncology, ⚡ Energy & Fatigue, 🫁 Liver & Detox, 😴 Sleep, 🧠 Focus & Attention. The primary research focus is 🔬 Oncology with 41% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Daunorubicin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dactinomycin
37 shared targets
Emetine
33 shared targets
Camptothecin
34 shared targets
Idarubicin
29 shared targets
o-Phthalaldehyde
28 shared targets
Ethidium
44 shared targets
Rotenone
32 shared targets
Ethinyl
35 shared targets
Melphalan
29 shared targets
Nocodazole
34 shared targets
Loading evidence profile...

This evidence profile for Daunorubicin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.